Review: could Elmiron cause Infusion related reaction?
We study 1,867 people who have side effects while taking Elmiron from FDA and social media. Among them, 7 have Infusion related reaction. Find out below who they are, when they have Infusion related reaction and more.
Stay connected: join a mobile support group for people who take Elmiron and have Infusion related reaction >>>
Elmiron (latest outcomes from 1,983 users) has active ingredients of pentosan polysulfate sodium. It is often used in interstitial cystitis (ic).
Infusion related reaction
Infusion related reaction (latest reports from 55,742 patients) has been reported by people with crohn's disease, rheumatoid arthritis, premedication, multiple sclerosis, ulcerative colitis.
On Jul, 23, 2014: 1,867 people reported to have side effects when taking Elmiron. Among them, 7 people (0.37%) have Infusion Related Reaction. They amount to 0.01% of all the 55,742 people who have Infusion Related Reaction on eHealthMe.
Time on Elmiron when people have Infusion related reaction * :
Gender of people who have Infusion related reaction when taking Elmiron * :
|Infusion related reaction||100.00%||0.00% |
Age of people who have Infusion related reaction when taking Elmiron * :
|Infusion related reaction||0.00%||0.00%||0.00%||0.00%||16.67%||83.33%||0.00%||0.00% |
Severity of Infusion related reaction when taking Elmiron ** :
How people recovered from Infusion related reaction ** :
Top conditions involved for these people * :
- Crohn's disease (5 people, 71.43%)
- Rheumatoid arthritis (4 people, 57.14%)
- Colitis ulcerative (4 people, 57.14%)
- Hormone replacement therapy (4 people, 57.14%)
- Cystitis interstitial (4 people, 57.14%)
Top co-used drugs for these people * :
- Remicade (5 people, 71.43%)
- Lexapro (4 people, 57.14%)
- Asacol (4 people, 57.14%)
- Estrogenic substance (4 people, 57.14%)
- Unspecified crohn's disease therapy (4 people, 57.14%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
Comments from related studies:
From this study (4 months ago):
Stools problem is ok.. but I'm scared about hair lose
From this study (1 year ago):
I was given this drug for pain in lower left pelvic area, after 3 doses, I lost control of my ability to control urination and urine just flows out
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Elmiron, Infusion related reaction
More reviews for: Elmiron, Infusion related reaction
On eHealthMe, Elmiron (pentosan polysulfate sodium) is often used for interstitial cystitis (ic). Find out below the conditions Elmiron is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Elmiron used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Drugs in real world that are associated with:
Could your condition cause it?
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.